Treating COVID-19 Based on Disease Severity: Key Considerations in Hospitalized Patients

Overview:,In this educational activity, expert faculty will discuss the use of approved and authorized treatments for the management of patients hospitalized with COVID-19. A review of clinical trial data on the efficacy and safety of therapeutic options and strategies for selecting therapy based on disease severity and clinical factors will allow clinicians to reduce the need for invasive ventilation and improve patient outcomes.,Learning Objectives:,Upon the completion of this program, attendees should be able to:,• Evaluate clinical trial of therapies with EUAs for treating patients with COVID-19,• Choose appropriate treatment across the spectrum of disease severity in hospitalized patients with COVID-19,• Explain the impact of SARS-CoV-2 variants on the efficacy and safety of EUA therapies for the treatment of COVID-19 in improving clinical outcomes among hospitalized patients,• Recognize best practices for use of immunosuppressive therapies to reduce the need for invasive ventilation in patients admitted to intensive care units,• Use tools and resources developed to promote the delivery of therapies to people with COVID-19 including underserved populations